The Effect of Captopril on Experimentally Induced Benign Prostatic Hyperplasia

Fatma Mostafa Zaki Mostafa;

Abstract


This study was conducted to investigate the potential protective effect of captopril against testosterone-induced benign prostatic hyperplasia in rats and elucidate the underlying molecular mechanisms.
Experimental design:

1) Screening study
To select the most effective dose of Cap. In this study, rats were divided into 5 groups and treated for 5 consecutive days per week for 4 successive weeks:
-Group 1: animals in this group served as the control and were given vehicles only.
-Group 2: animals in this group served as the BPH model and were injected with testosterone (3 mg/kg) subcutaneously.
-Groups 3, 4 and 5: animals in these groups were given Cap at doses of (25, 50 and 100 mg/kg) respectively, dissolved in saline orally 1hr prior to testosterone injection.
Assessed parameters:

- Prostate weight
- Prostatic index (Prostate weight/ Body weight ratio)
- PAP
- PSA
- Histological examination (H&E)
This study revealed that Cap (100 mg/kg) is the most effective dose since it significantly decreased the prostate weight, prostatic index


Other data

Title The Effect of Captopril on Experimentally Induced Benign Prostatic Hyperplasia
Other Titles "تأثير الكابتوبريل على تضخم البروستاتا الحميد المحدث تجريبيا"
Authors Fatma Mostafa Zaki Mostafa
Issue Date 2017

Attached Files

File SizeFormat
J5417.pdf749.92 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.